Regional Analysis

Mitral Valve Disease Market Regional Insights

To learn more about this report, Request sample copy

Dominating Region- North America

North America is expected to dominate the mitral valve disease market with an estimated market share of 39.2% in 2024, due to factors such as high healthcare expenditure, strong presence of leading medical device companies, and supportive reimbursement structures in countries like the U.S.

Fastest-Growing Region- Asia Pacific

Asia Pacific region exhibits the fastest growth due to rising geriatric population, growing medical tourism, increasing healthcare expenditure, and expansions by major industry players looking to tap into the region's high potential.

Mitral Valve Disease Market Outlook for Key Countries

U.S.- Leading Market with Advanced Healthcare Infrastructure

The U.S. is the largest market for mitral valve disease due to high healthcare expenditure and advanced medical technology. In May 2024, according to the American Heart Association, approximately 2 million people in the U.S. suffer from mitral valve regurgitation, thus, boosting demand for treatment options. The advanced healthcare infrastructure supports a wide range of innovative treatments and technologies in cardiology, including mitral valve interventions.

Canada- Growing Adoption of Innovative Treatments

Canada's healthcare system is increasingly adopting advanced mitral valve treatments, with a reported 15% increase in mitral valve surgeries from 2022 to 2023, as per the Canadian Institute for Health Information. In February 2024, as per the Hospital Stays in Canada, 2022–2023 Report, there were 2.96 million acute inpatient hospitalizations in Canada during that period, increase from 2.88 million in 2021–2022. The most common inpatient surgeries included caesarean sections, knee replacements, and hip replacements.

China- Expanding Market with Increasing Healthcare Investments

China's mitral valve disease market is indeed expanding rapidly, driven by significant investments in healthcare infrastructure and increasing number of surgical procedures. In August 2023, according to National Library of Medicine, there has been a notable increase in the number of mitral valve surgeries performed in 2023, reflecting the government's commitment to enhancing cardiac care across the country.

India- India's Mitral Valve Disease Market Witnesses Significant Growth Due to Increased Healthcare Awareness

India is experiencing significant growth in the mitral valve disease market, driven by increased healthcare awareness, improved access to cardiac care, and a growing middle class seeking advanced medical treatments. In December 2022, the total number of surgical heart valve procedures performed in India was 30,896. The conventional mitral valve procedure was the most performed surgical heart valve procedure in 2022 in India.